Susquehanna International Group
ARNA

Susquehanna International Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Susquehanna International Group’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-327,300
Closed -$30.4M – 14535
2021
Q4 		$30.4M Buy
327,300
+154,800
+90% +$10.2M ﹤0.01% 1459
2021
Q3 		$10.3M Buy
172,500
+84,100
+95% +$4.97M ﹤0.01% 2824
2021
Q2 		$6.03M Buy
88,400
+34,900
+65% +$2.28M ﹤0.01% 3680
2021
Q1 		$3.71M Sell
53,500
-50,300
-48% -$3.87M ﹤0.01% 4503
2020
Q4 		$7.97M Sell
103,800
-137,200
-57% -$10.3M ﹤0.01% 2776
2020
Q3 		$18M Buy
241,000
+50,700
+27% +$3.38M ﹤0.01% 1574
2020
Q2 		$12M Buy
190,300
+49,800
+35% +$2.74M ﹤0.01% 1932
2020
Q1 		$5.9M Buy
140,500
+64,200
+84% +$2.94M ﹤0.01% 2365
2019
Q4 		$3.47M Buy
76,300
+8,500
+13% +$402K ﹤0.01% 3476
2019
Q3 		$3.1M Sell
67,800
-58,500
-46% -$3.29M ﹤0.01% 3429
2019
Q2 		$7.41M Sell
126,300
-19,900
-14% -$1.03M ﹤0.01% 2229
2019
Q1 		$6.55M Buy
146,200
+72,700
+99% +$3.33M ﹤0.01% 2154
2018
Q4 		$2.86M Sell
73,500
-63,000
-46% -$2.47M ﹤0.01% 3015
2018
Q3 		$6.28M Sell
136,500
-17,200
-11% -$697K ﹤0.01% 2403
2018
Q2 		$6.7M Sell
153,700
-11,700
-7% -$503K ﹤0.01% 2384
2018
Q1 		$6.53M Sell
165,400
-334,200
-67% -$13M ﹤0.01% 2210
2017
Q4 		$17M Sell
499,600
-14,700
-3% -$419K 0.01% 1378
2017
Q3 		$13.1M Sell
514,300
-24,300
-5% -$557K 0.01% 1554
2017
Q2 		$9.09M Buy
538,600
+518,590
+2,592% +$7.11M ﹤0.01% 1781
2017
Q1 		$292K Sell
20,010
-15,890
-44% -$235K ﹤0.01% 7378
2016
Q4 		$510K Sell
35,900
-5,570
-13% -$86.3K ﹤0.01% 6963
2016
Q3 		$726K Sell
41,470
-3,890
-9% -$64.5K ﹤0.01% 5395
2016
Q2 		$776K Buy
45,360
+3,800
+9% +$67.9K ﹤0.01% 5355
2016
Q1 		$819K Buy
41,560
+4,350
+12% +$69.7K ﹤0.01% 5489
2015
Q4 		$707K Sell
37,210
-3,000
-7% -$61.2K ﹤0.01% 6121
2015
Q3 		$768K Sell
40,210
-18,850
-32% -$640K ﹤0.01% 6274
2015
Q2 		$2.74M Buy
59,060
+27,220
+85% +$1.18M ﹤0.01% 4026
2015
Q1 		$1.39M Sell
31,840
-64,120
-67% -$2.98M ﹤0.01% 5083
2014
Q4 		$3.33M Sell
95,960
-2,650
-3% -$108K ﹤0.01% 3551
2014
Q3 		$4.13M Sell
98,610
-52,550
-35% -$2.35M ﹤0.01% 3308
2014
Q2 		$8.86M Sell
151,160
-97,230
-39% -$6.12M ﹤0.01% 2250
2014
Q1 		$15.6M Sell
248,390
-74,160
-23% -$4.92M 0.01% 1512
2013
Q4 		$18.9M Buy
322,550
+91,150
+39% +$4.76M 0.01% 1402
2013
Q3 		$12.2M Sell
231,400
-102,570
-31% -$6.89M 0.01% 1689
2013
Q2 		$25.7M Buy
+333,970
New +$27.3M 0.01% 918

Susquehanna International Group's ARNA Position: Q1 2022 in Review

Susquehanna International Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 190,490 shares — an estimated $17.7M sold.

Susquehanna International Group first reported a position in ARNA in Q2 2013 and held it in 33 quarters. The position peaked at $23.8M in Q2 2014. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Susquehanna International Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Susquehanna International Group sold 190,490 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $17.7M.
  • Susquehanna International Group first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 33 quarters.
  • Susquehanna International Group's Arena Pharmaceuticals Inc position peaked at $23.8M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.